STOCK TITAN

DSS gets $500K note, 8M warrants from Alset

DSS, Inc. secured a $500,000 related-party convertible loan plus 8 million warrants from Alset Inc., subject to stockholder approval for any equity issuance.

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

DSS, Inc. (DSS) entered into a related-party securities purchase agreement with Alset Inc. under which Alset loaned DSS $500,000 in exchange for a convertible promissory note and warrants for up to 8,000,000 common shares. The note carries 3% simple interest and is payable on demand, with a five-year maturity.

Alset may convert principal and interest into common stock at $0.50 per share, and the warrants are exercisable at $0.55 per share for five years. Conversion of the note and exercise of the warrants both require stockholder approval. DSS and Alset are under common control through Chairman Chan Heng Fai, and the board and audit committee approved the transaction.

Positive

  • $500,000 in new financing at a relatively low 3% simple interest with five-year maturity provides additional liquidity.
  • Conversion price of $0.50 per share and warrant exercise price of $0.55 help establish a negotiated valuation benchmark with a significant existing shareholder.

Negative

  • Issuance of a convertible note and 8,000,000 warrants at prices of $0.50–$0.55 per share creates potential dilution if stockholders approve conversion and exercise.
  • The transaction is a related-party deal under common control of Chairman Chan Heng Fai, increasing governance and conflict-of-interest scrutiny despite board and audit committee approval.
  • The note is payable upon demand, introducing potential refinancing or repayment pressure if Alset requests payment before maturity.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Loan principal $500,000 Principal amount loaned by Alset Inc. to DSS under the securities purchase agreement
Note interest rate 3% per annum Simple interest rate on the convertible promissory note
Conversion price $0.50 per share Price at which Alset may convert note principal and interest into DSS common stock
Warrants shares 8,000,000 shares Maximum number of DSS common shares purchasable under the warrants issued to Alset
Warrant exercise price $0.55 per share Exercise price for the 8,000,000 DSS common stock purchase warrants
Note maturity 5 years Maturity period from date of the convertible promissory note
Warrant term 5 years Expiration period for the common stock purchase warrants
Securities Purchase Agreement financial
"entered into a securities purchase agreement (the “SPA”) with Alset Inc."
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
convertible promissory note financial
"in exchange for a convertible promissory note (the “Note”) and warrants"
A convertible promissory note is a loan a company takes now that can later be turned into shares instead of being repaid in cash. Think of it as lending money with the option to accept ownership in the business down the road; that matters to investors because it affects who gets paid first, how much ownership existing shareholders keep, and the company’s future valuation and cash needs. Terms such as conversion price, interest and maturity determine the financial impact.
warrants financial
"warrants to purchase 8,000,000 shares of the Company’s common stock"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
simple interest financial
"The Note bears simple interest at 3% per annum."
Simple interest is a way of calculating interest where payments are based only on the original amount lent or invested, not on interest that accumulates over time. Think of it like getting a fixed tip each period on the initial bill rather than earning interest on the tip itself; it keeps returns predictable and makes it easy for investors and borrowers to compare total interest cost or income over a set term.
material definitive agreement regulatory
"Item 1.01 Entry into a Material Definitive Agreement."
A material definitive agreement is a legally binding contract that creates major, long‑term obligations or rights for a company, such as loans, asset sales, mergers, or supplier deals. Think of it like a mortgage or lease for a business: it can change future cash flow, risk and control, so investors watch these agreements closely because they can materially affect a company’s value, financial health and stock price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What financing transaction did DSS (DSS) announce with Alset Inc.?

DSS entered into a securities purchase agreement where Alset Inc. loaned $500,000 to DSS in return for a convertible promissory note and warrants to purchase up to 8,000,000 DSS common shares.

What are the key terms of the DSS (DSS) convertible promissory note with Alset?

The note bears 3% simple interest per year, is payable on demand, and has a five-year maturity. Alset may convert outstanding principal and interest into DSS common stock at a price of $0.50 per share, subject to stockholder approval.

What are the warrant terms in the DSS (DSS) agreement with Alset?

Alset received warrants to purchase up to 8,000,000 DSS common shares at an exercise price of $0.55 per share. The warrants have a five-year term, and exercise requires DSS stockholder approval under the transaction documents.

Why is stockholder approval required for the DSS (DSS) Alset transaction?

The transaction documents require stockholder approval before Alset can convert the note into shares or exercise the warrants. Without this approval, the equity issuances underlying the note conversion and warrant exercise cannot occur.

Who approved the DSS (DSS) securities purchase agreement with Alset?

The transaction documents, including the securities purchase agreement, note, and warrants, were approved by DSS’s Board of Directors and its Audit Committee, according to the disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0000771999 0000771999 2026-09-15 2026-09-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 15, 2026

 

DSS, INC.

(Exact name of registrant as specified in its charter)

 

New York   001-32146   16-1229730

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

275 Wiregrass Pkwy,

West Henrietta, NY

  14586
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (585) 325-3610

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Ticker symbol(s)   Name of each exchange on which registered
Common Stock, $0.02 par value per share   DSS   The NYSE American LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

Securities Purchase Agreement with Alset Inc.

 

On September 15, 2026, DSS, Inc. (the “Company”) entered into a securities purchase agreement (the “SPA”) with Alset Inc., a Texas corporation (“Alset”), pursuant to which Alset has loaned the Company $500,000, in exchange for a convertible promissory note (the “Note”) and warrants to purchase 8,000,000 shares of the Company’s common stock (the “Warrants”). The Note, SPA, and Warrants are collectively referred to herein as the “Transaction Documents.”

 

The Note is payable upon demand. The Note bears simple interest at 3% per annum. Alset may convert any outstanding principal and interest into shares of the Company’s common stock at $0.50 per share upon notice prior to maturity of the Note, which is five (5) years from the date thereof.

 

The Warrants are to purchase up to 8,000,000 shares of the Company’s common stock at an exercise price of $0.55 per share. The Warrants expire on their fifth anniversary.

 

The Transaction Documents will require the approval of the Company’s stockholders prior to the conversion of the Note or exercise of the Warrants.

 

Alset holds a significant equity interest in the Company directly and through its subsidiaries. The Company and Alset are related parties under the common control of the Company’s Chairman, Chan Heng Fai, who is also the Chairman and Chief Executive Officer of Alset. Chan Tung Moe, a director and Co-Chief Executive Officer of Alset, is also a director of the Company. Lim Sheng Hon Danny, a director and officer of Alset, is also a director of the Company. Three of the Company’s independent directors, Joanne Wong Hiu Pan, Wong Shui Yeung, and William Wu, are also directors of Alset.

 

The Transaction Documents were approved by the Company’s Board of Directors and Audit Committee.

 

The foregoing is a summary only and does not purport to be complete. It is qualified in its entirety by reference to the Transaction Documents, copies of which are filed as Exhibits 10.1, 10.2, and 10.3 hereto and incorporated by reference herein.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits:

 

Exhibit No.   Description
10.1   Securities Purchase Agreement, between DSS, Inc. and Alset Inc., dated as of September 15, 2026
10.2   Form of Convertible Promissory Note, between DSS, Inc. and Alset Inc.
10.3   Form of Common Stock Purchase Warrant of DSS, Inc.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

  DSS, INC.
     
Date: September 21, 2026 By: /s/ Jason Grady
  Name: Jason Grady
  Title: Interim Chief Executive Officer

 

 

 

Filing Exhibits & Attachments

6 documents

Keep reading